Elma Feric Bojic

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain. We have previously reported on a number of structurally distinct bicyclic(More)
  • 1